NET PROFIT (x1000 NOK)
EMPLOYEES
Epista Life Science A/S
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
18,806
|
6,947
|
14,333 |
| Total assets |
122,675
|
76,635
|
33,786 |
| Current assets |
63,463
|
30,697
|
27,418 |
| Current liabilities |
59,783
|
35,857
|
14,121 |
| Equity capital |
58,827
|
40,778
|
19,665 |
| - share capital |
790
|
742
|
703 |
| Employees (average) |
35
|
35
|
35 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
48.0%
|
53.2%
|
58.2% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
106.2%
|
85.6%
|
194.2% |
| Return on equity (ROE) |
32.0%
|
17.0%
|
72.9% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.